Skip to main navigation
Skip to search
Skip to main content
Sort by
Biochemistry, Genetics and Molecular Biology
Glucagon-Like Peptide 1 Receptor
49%
Receptor Agonists
39%
Therapeutic Protein
29%
Protein Structure Prediction
29%
Glucagon-Like Peptide-1
29%
Crystallin
29%
Incretin
29%
Mouse Model
24%
Sucrose
24%
Glucagon Release
24%
Cryoelectron Microscopy
19%
Mutant Protein
19%
Insulin Release
19%
Endocytosis
14%
Missense
14%
Liver Metabolism
14%
Glucose Blood Level
14%
Wild Type
14%
Gantenerumab
11%
Fat
9%
Gene
9%
Signal Transduction
9%
CRISPR/Cas9
9%
Cyclic Adenosine Monophosphate
9%
Dynamics
9%
G Protein Coupled Receptor
9%
Amyloid Protein
9%
Heat Shock Protein
9%
Cell Death
9%
Cytotoxicity
9%
Cysteine
9%
Glucose Homeostasis
9%
C-Peptide
9%
Enzymatic Degradation
9%
Pharmacokinetic
9%
Insulin Resistance
9%
Hyperglycemia
9%
Cellular, Subcellular and Molecular Biological Phenomena and Functions
7%
Optimism
7%
Synuclein
5%
Crenezumab
5%
Solanezumab
5%
Neuroscience
Antibodies
29%
Malaria
29%
Vertebral Column
29%
Neurodegenerative Disorder
29%
Receptor Trafficking
29%
Categorization
29%
Ligand
29%
Glucagon-Like Peptide-1
29%
Crystallin
29%
Glucagon-Like Peptide 1 Receptor
19%
Dilated Cardiomyopathy
19%
Chaperone
19%
Mutant Protein
19%
Brain
17%
Endocytosis
14%
Receptor
14%
G Protein Coupled Receptor
9%
Cyclic Adenosine Monophosphate
9%
Cell Protein
9%
Monomer
9%
Small Heat Shock Protein
9%
Amyloid Protein
9%
Muscle Protein
9%
Cell Death
9%
Oligomer
9%
Cysteine
9%
Cytotoxicity
9%
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
100%
Drug Development
64%
Glucagon-Like Peptide-1
29%
Computer-Aided Drug Design
29%
Calcitonin Receptor
29%
Amylin Receptor
29%
Clinical Trial
29%
Amylin
22%
Glucagon-Like Peptide 1 Receptor
19%
Rare Disease
14%
Fibrosing Alveolitis
14%
Fragile X Syndrome
14%
Target Identification
14%
Cyclic AMP
9%
Therapeutic Effect
9%
Pharmacokinetic
9%
Insulin Resistance
9%
Glucagon
9%
C Peptide
9%
Incretin
7%
Calcitonin
7%
Metabolic Disorder
7%
Salcatonin
7%